BMS is spinning out a new company with five immunology assets, including oral drugs being developed for systemic lupus ...

Bristol Myers Squibb is spinning off a fresh company armed with five autoimmune disease drugs and $300 million in Bain ...

David V. Elkins currently works at Tapestry, Inc., as Independent Director from 2024 and Bristol Myers Squibb Co., as Chief Financial Officer & Executive Vice President. Mr. Elkins also formerly ...